PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

Insider Reports History

Location
Wilmington, NC
Signature
Jaguar Holding Company II By: /s/ Julia James, Name: Julia James, Title: General Counsel and Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Science 37 Holdings, Inc. 10%+ Owner Common Stock 17,379,797 $7,099,647 $0.4085 06 Oct 2021 Direct

Insider Reports Filed by PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000162828021022213-pharmaceutical-product-development-llc-2021-10-06-restatement Science 37 Holdings, Inc. 06 Oct 2021 0 $0 3/A 10%+ Owner 08 Nov 2021, 15:09